» Articles » PMID: 23498955

HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex

Abstract

Hepatitis C virus (HCV) entry is dependent on coreceptor complex formation between the tetraspanin superfamily member CD81 and the tight junction protein claudin-1 (CLDN1) on the host cell membrane. The receptor tyrosine kinase EGFR acts as a cofactor for HCV entry by promoting CD81-CLDN1 complex formation via unknown mechanisms. We identify the GTPase HRas, activated downstream of EGFR signaling, as a key host signal transducer for EGFR-mediated HCV entry. Proteomic analysis revealed that HRas associates with tetraspanin CD81, CLDN1, and the previously unrecognized HCV entry cofactors integrin β1 and Ras-related protein Rap2B in hepatocyte membranes. HRas signaling is required for lateral membrane diffusion of CD81, which enables tetraspanin receptor complex assembly. HRas was also found to be relevant for entry of other viruses, including influenza. Our data demonstrate that viruses exploit HRas signaling for cellular entry by compartmentalization of entry factors and receptor trafficking.

Citing Articles

Functional Role of Hepatitis C Virus NS5A in the Regulation of Autophagy.

Ke P, Yeh C Pathogens. 2024; 13(11).

PMID: 39599533 PMC: 11597459. DOI: 10.3390/pathogens13110980.


Hepatitis B virus entry, assembly, and egress.

Chuang Y, Ou J Microbiol Mol Biol Rev. 2024; 88(4):e0001424.

PMID: 39440957 PMC: 11653734. DOI: 10.1128/mmbr.00014-24.


Targeting NTCP for liver disease treatment: A promising strategy.

Tan X, Xiang Y, Shi J, Chen L, Yu D J Pharm Anal. 2024; 14(9):100979.

PMID: 39310850 PMC: 11415714. DOI: 10.1016/j.jpha.2024.100979.


After the Storm: Persistent Molecular Alterations Following HCV Cure.

Seurre C, Roca Suarez A, Testoni B, Zoulim F, Grigorov B Int J Mol Sci. 2024; 25(13).

PMID: 39000179 PMC: 11241208. DOI: 10.3390/ijms25137073.


RABV induces biphasic actin cytoskeletal rearrangement through Rac1 activity modulation.

Liu X, Xu J, Zhang M, Wang H, Guo X, Zhao M J Virol. 2024; 98(7):e0060624.

PMID: 38809020 PMC: 11264595. DOI: 10.1128/jvi.00606-24.